SCHEMBL5752032

SCHEMBL5752032

O=Cc1cc([N+](=O)[O-])cc2c(Cl)nc(Cl)nc12

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.41
▸ OPRK1 P41145 1/20 0.41
▸ ERN1 O75460 2/20 0.40
▸ PTPN1 P18031 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ AMY1A P0DUB6 1/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ LCK P06239 1/20 0.32
▸ CYP19A1 P11511 1/20 0.32
▸ ACHE P22303 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ MPI P34949 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ GPR35 Q9HC97 1/20 0.31
▸ APEX1 P27695 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5756383 0.79 NQO2 (0.47) KMT2AOPRK1ALDH1A1AMY1AMEN1
SCHEMBL29532414 0.72 KMT2A (0.67) KMT2AOPRK1ALDH1A1MEN1ACHE
SCHEMBL2263219 0.72 KMT2A (0.67) KMT2AOPRK1ALDH1A1MEN1ACHE
SCHEMBL5754517 0.71 KMT2A (0.38) KMT2AOPRK1ALDH1A1MEN1KDM4E
SCHEMBL12328353 0.68 ERN1 (0.46) KMT2AERN1ALDH1A1AMY1AMEN1
SCHEMBL4113627 0.68 KMT2A (0.43) KMT2AOPRK1ALDH1A1MEN1MAPT
SCHEMBL28133331 0.68 KMT2A (0.60) KMT2AOPRK1ERN1PTPN1ALDH1A1
SCHEMBL3644484 0.67 ALDH1A1 (0.67) KMT2AERN1ALDH1A1AMY1AMEN1
SCHEMBL12104188 0.66 GPR35 (0.49) KMT2AERN1ALDH1A1MEN1KDM4E
SCHEMBL8129389 0.66 KMT2A (0.55) KMT2AOPRK1ALDH1A1MEN1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218358-B1 THERAPEUTIC QUINAZOLINE COMPOUNDS ASTRAZENECA AB (SE) 2006-09-13 — — EP disclosed
EP-1218358-A1 THERAPEUTIC QUINAZOLINE COMPOUNDS AstraZeneca AB (SE) 2002-07-03 — — EP disclosed
US-6399603-B1 QUINAZOLINES; RETARDING APOPTOSIS IN CELLS; INHIBITING CLEAVAGE OF PROTEIN SUBSTRATES BY CASPASE-3; CHEMICAL AND HYDROLYTIC STABILITY ASTRAZENECA AB (SE) 2002-06-04 — — US disclosed
WO-2001021598-A1 THERAPEUTIC QUINAZOLINE COMPOUNDS ASTRAZENECA AB (SE) 2001-03-29 — — WO disclosed
Send feedback